Faderl, S., Ferrajoli, A., Wierda, W., O'Brien, S., Lerner, S., & Keating, M. J. (2010). Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence. Cancer.
シカゴスタイル引用形Faderl, Stefan, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, , Michael J. Keating. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.
MLA引用形式Faderl, Stefan, et al. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.